LEE SPENCER S — SEC insider filings

SEC reporting owner CIK 1207134. 40 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 40 filings on record, filed 2020-09-15 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CHEMED CORP (CHE)executive vice president40—17 legs · 23,561 sh · $12,878,20970

Insider filings — LEE SPENCER S

FiledFormIssuerReported transactionsSource
2026-11-164CHEMED CORP (CHE)Gift (G): 60 @ $0EDGAR
2026-11-134CHEMED CORP (CHE)Sale (S): 1,000 @ $547.61EDGAR
2026-11-034CHEMED CORP (CHE)Sale (S): 920 @ $537.17EDGAR
2026-10-224CHEMED CORP (CHE)Grant/award (A): 7,125 (derivative) @ $512.64EDGAR
2026-10-014CHEMED CORP (CHE)Option exercise (M): 12,099 @ $445.35 · Tax withholding (F): 11,160 @ $508.93 · Option exercise (M): 12,099 (derivative) @ $445.35EDGAR
2026-08-244CHEMED CORP (CHE)Sale (S): 1,000 @ $541.04EDGAR
2026-02-174CHEMED CORP (CHE)Option exercise (M): 499 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 154 @ $469.56 · Option exercise (M): 402 (derivative) @ $0 · Option exercise (M): 402 (derivative) @ $0 · Grant/award (A): 960 (derivative) @ $0EDGAR
2025-11-194CHEMED CORP (CHE)Gift (G): 60 @ $0EDGAR
2025-10-224CHEMED CORP (CHE)Grant/award (A): 12,759 (derivative) @ $443.79EDGAR
2025-05-194CHEMED CORP (CHE)Sale (S): 1,500 @ $577.99EDGAR
2025-05-084CHEMED CORP (CHE)Sale (S): 1,500 @ $577.86EDGAR
2025-03-034CHEMED CORP (CHE)Sale (S): 1,326 @ $592.25EDGAR
2025-02-184CHEMED CORP (CHE)Option exercise (M): 824 @ $553.39 · Option exercise (M): 249 @ $553.39 · Tax withholding (F): 342 @ $553.39 · Option exercise (M): 408 (derivative) @ $0 · Option exercise (M): 408 (derivative) @ $0 · Grant/award (A): 822 (derivative) @ $0EDGAR
2024-12-024CHEMED CORP (CHE)Gift (G): 65 @ $0EDGAR
2024-11-294CHEMED CORP (CHE)Sale (S): 732 @ $575.62EDGAR
2024-11-224CHEMED CORP (CHE)Sale (S): 1,000 @ $565.71EDGAR
2024-10-234CHEMED CORP (CHE)Grant/award (A): 9,105 (derivative) @ $597.70EDGAR
2024-08-094CHEMED CORP (CHE)Sale (S): 1,016 @ $580.48 · Option exercise (M): 9,000 @ $413.19 · Tax withholding (F): 7,592 @ $578.31 · Option exercise (M): 9,000 (derivative) @ $413.19EDGAR
2024-05-014CHEMED CORP (CHE)Gift (G): 1,133 @ $0EDGAR
2024-04-014CHEMED CORP (CHE)Sale (S): 2,000 @ $641.65 · Option exercise (M): 13,000 @ $106.59 · Tax withholding (F): 7,080 @ $643.78 · Option exercise (M): 13,000 (derivative) @ $106.59EDGAR
2024-02-204CHEMED CORP (CHE)Option exercise (M): 192 @ $586.49 · Option exercise (M): 288 @ $586.49 · Tax withholding (F): 154 @ $586.49 · Option exercise (M): 308 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 · Grant/award (A): 742 (derivative) @ $0EDGAR
2023-11-274CHEMED CORP (CHE)Sale (S): 1,000 @ $579.73EDGAR
2023-11-134CHEMED CORP (CHE)Gift (G): 65 @ $0EDGAR
2023-11-084CHEMED CORP (CHE)Sale (S): 1,217 @ $583.85EDGAR
2023-10-264CHEMED CORP (CHE)Grant/award (A): 11,015 (derivative) @ $509.46EDGAR
2023-02-224CHEMED CORP (CHE)Option exercise (M): 519 @ $515.12 · Option exercise (M): 296 @ $515.12 · Tax withholding (F): 313 @ $515.12 · Option exercise (M): 257 (derivative) @ $0 · Option exercise (M): 257 (derivative) @ $0 · Grant/award (A): 804 (derivative) @ $0EDGAR
2022-11-164CHEMED CORP (CHE)Option exercise (M): 8,000 @ $306.70 · Tax withholding (F): 6,268 @ $493.84 · Option exercise (M): 8,000 (derivative) @ $306.70EDGAR
2022-11-084CHEMED CORP (CHE)Sale (S): 2,000 @ $490.09EDGAR
2022-11-024CHEMED CORP (CHE)Grant/award (A): 12,320 (derivative) @ $462.04EDGAR
2022-03-084CHEMED CORP (CHE)Sale (S): 1,054 @ $487.39EDGAR
2022-02-234CHEMED CORP (CHE)Option exercise (M): 669 @ $459.77 · Option exercise (M): 436 @ $459.77 · Tax withholding (F): 532 @ $459.77 · Option exercise (M): 331 (derivative) @ $0 · Option exercise (M): 331 (derivative) @ $0 · Grant/award (A): 816 (derivative) @ $0EDGAR
2021-12-134CHEMED CORP (CHE)Gift (G): 90 @ $0EDGAR
2021-11-154CHEMED CORP (CHE)Option exercise (M): 9,000 @ $231.91 · Tax withholding (F): 6,486 @ $500.02 · Option exercise (M): 9,000 (derivative) @ $231.91EDGAR
2021-11-024CHEMED CORP (CHE)Sale (S): 2,000 @ $489.13 · Grant/award (A): 12,099 (derivative) @ $445.35EDGAR
2021-06-174CHEMED CORP (CHE)Gift (G): 1,982 @ $0EDGAR
2021-02-234CHEMED CORP (CHE)Option exercise (M): 852 @ $491.34 · Option exercise (M): 695 @ $491.34 · Tax withholding (F): 735 @ $491.34 · Option exercise (M): 422 (derivative) @ $0 · Option exercise (M): 422 (derivative) @ $0 · Grant/award (A): 616 (derivative) @ $0EDGAR
2020-12-074CHEMED CORP (CHE)Gift (G): 70 @ $0 · Gift (G): 15 @ $0EDGAR
2020-11-064CHEMED CORP (CHE)Sale (S): 2,153 @ $506.96 · Option exercise (M): 13,600 @ $135.85 · Tax withholding (F): 8,383 @ $509.60 · Option exercise (M): 13,600 (derivative) @ $135.85EDGAR
2020-10-304CHEMED CORP (CHE)Grant/award (A): 10,018 (derivative) @ $471.74EDGAR
2020-09-154CHEMED CORP (CHE)Sale (S): 2,143 @ $495.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1207134 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs